Category Pharma/Biotech

CogniSHIELD Global Launches CogniSHIELD® ADVANCED, a Brain Health Supplement Backed by 12 Years of Research

CogniSHIELD Global Launches ADVANCED Brain Health Supplement Featuring Four Key Ingredients and 12 Years of Research CogniSHIELD Global has introduced CogniSHIELD® ADVANCED, a dietary supplement developed to support memory, recall,…

Read MoreCogniSHIELD Global Launches CogniSHIELD® ADVANCED, a Brain Health Supplement Backed by 12 Years of Research

Burjeel Holdings Partners With UK-Based Avatrial to Develop Abu Dhabi’s First AI-Powered Cancer Drug Discovery Ecosystem

Burjeel Holdings and Avatrial Partner to Develop AI-Powered Cancer Drug Discovery Ecosystem in Abu Dhabi Strategic Partnership Aims to Accelerate Cancer Research and Therapeutic Innovation Burjeel Holdings, a leading super-specialty…

Read MoreBurjeel Holdings Partners With UK-Based Avatrial to Develop Abu Dhabi’s First AI-Powered Cancer Drug Discovery Ecosystem

Fresenius Acquires Remaining 45% Stake in mAbxience for Up to €750 Million, Securing Full Ownership of Biosimilars Platform

Fresenius Acquires Remaining 45% of mAbxience for Up to €750 Million, Taking Full Ownership of Biosimilars Platform Fresenius SE & Co. KGaA has completed the acquisition of the remaining 45%…

Read MoreFresenius Acquires Remaining 45% Stake in mAbxience for Up to €750 Million, Securing Full Ownership of Biosimilars Platform

Compass Pathways Announces U.S. Grant Program Recipients to Support Post-Approval COMP360 Provider Training

Compass Pathways Announces U.S. Grant Program Recipients to Support Post-Approval COMP360 Provider Training Compass Pathways , a biotechnology company focused on developing new treatment options for mental health conditions, has…

Read MoreCompass Pathways Announces U.S. Grant Program Recipients to Support Post-Approval COMP360 Provider Training